Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Anti-cancer potential of sophoridine and its derivatives: Recent progress and future perspectives
Haroon Ur Rashid1, Shagufta Rasool2, Yousaf Ali2
1Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil; Department of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Abstract:
Cancer is the second leading cause of mortality and has resulted in about 9.6 million deaths around the world in 2018. Cancer-caused deaths are expected to be 11.5 million by 2030 all over the world. Because of the fatal nature of cancer, substantial efforts are made all over the world to combat it. Phytoconstituents such as certain alkaloids, saponins, tannins, polyphenols, and terpenoids exhibit anticancer effects. Sophoridine is a tetracyclic quinolizidine alkaloid isolated from the stem and leaves of medicinal plants Sophora alopecuroides L., and Euchresta japonica Benth, and roots of Sophora alopecuroides Ait. Chinese Food and Drug Administration (CFDA) approved sophoridine as an antitumor agent in 2005. This review covers the antitumor activities of sophoridine and its derivatives. The efficacy of sophoridine analogs is expressed with respect to their half-maximal inhibitory concentration (IC50 values). Structure-activity relationship (SAR) study for most of the sophoridine derivatives has been explained. Moreover, the current market of anticancer drugs and its expected growth are discussed. Prospects provide suggestions and clues for novel sophoridine-based anticancer agents with enhanced expected efficacy and minimum toxicity.
Insights
Sophoridine, a plant-derived alkaloid, shows significant antitumor activity. This review explores its anticancer potential, structure-activity relationships, and future development for novel cancer therapies.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Oncology
Background:
- Cancer is a leading cause of global mortality, necessitating novel therapeutic strategies.
- Phytoconstituents, including alkaloids like sophoridine, demonstrate promising anticancer effects.
- Sophoridine, derived from Sophora species, is approved in China as an antitumor agent.
Purpose of the Study:
- To review the antitumor activities of sophoridine and its derivatives.
- To analyze structure-activity relationships (SAR) of sophoridine analogs.
- To discuss the anticancer drug market and future prospects for sophoridine-based agents.
Main Methods:
- Literature review of studies on sophoridine and its derivatives.
- Analysis of reported half-maximal inhibitory concentration (IC50) values for efficacy.
- Examination of SAR studies to understand key structural features for activity.
Main Results:
- Sophoridine and its derivatives exhibit significant antitumor activities.
- SAR studies provide insights into optimizing sophoridine analogs for enhanced efficacy.
- The review details the efficacy of various sophoridine analogs.
Conclusions:
- Sophoridine holds potential as a basis for developing new anticancer drugs.
- Further research into sophoridine derivatives could lead to agents with improved efficacy and reduced toxicity.
- Understanding SAR is crucial for designing next-generation sophoridine-based cancer therapies.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...